Loading clinical trials...
Loading clinical trials...
Nicotine Dependence and Lung Cancer Genetics in African Americans
The study aims to understand the effects of learning about one's genetic risk for lung cancer that is specific to their ancestry. Participants will be given hypothetical personalized genetic risk results and ask to think about how they might respond to such information if they actually received such results.
The study aims to understand the effects of learning about one's genetic risk for lung cancer that is specific to their ancestry. Smokers will be randomized to receive hypothetical information about their genetic status and consider how they think they would respond if such results were actually presented to them. They will be randomly assigned to receive one of four sets of hypothetical genetic results: 1) High risk of lung cancer and high genetic African ancestry, 2) High risk of lung cancer and low genetic African ancestry, 3) Low risk of lung cancer and high genetic African ancestry, or 4) Low risk of lung cancer and low genetic African ancestry. After being given this hypothetical information, participants will complete brief questionnaires assessing perceived risk of lung cancer, worry about cancer, psychological distress, and motivation to quit smoking.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Hunter College
New York, New York, United States
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Start Date
September 1, 2018
Primary Completion Date
April 1, 2022
Completion Date
April 1, 2022
Last Updated
December 18, 2023
166
ACTUAL participants
HRHA
BEHAVIORAL
LRLA
BEHAVIORAL
HRLA
BEHAVIORAL
LRHA
BEHAVIORAL
Lead Sponsor
Temple University
Collaborators
NCT06498635
NCT05692635
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions